Hydroxychloroquine-induced Retinal Toxicity
Kaylene L. Carter, V. Diana
Abstract
Hydroxychloroquine (HCQ) retinopathy is rare, with an estimated 0.33% incidence before 5–7 years of therapy, increasing to 2.1% by 15 years1. A 62-year-old 59-kg woman with fibromyalgia and systemic lupus erythematosus presented to the ophthalmology clinic with blurry central vision in both eyes for several years. She had been taking 800 mg of HCQ daily for the past 8 years. Optical coherence tomography imaging revealed bilateral disruption of the outer retinal structures and …
Topics & Concepts
HydroxychloroquineMedicineRetinopathyRetinalOphthalmologyOptical coherence tomographyIncidence (geometry)DermatologyToxicityInternal medicineCoronavirus disease 2019 (COVID-19)EndocrinologyOpticsDiseasePhysicsInfectious disease (medical specialty)Diabetes mellitusDrug-Induced Ocular ToxicitySystemic Lupus Erythematosus ResearchOcular Diseases and Behçet’s Syndrome